Proud to partner in developing novel therapies for Multiple Sclerosis
Pharmidex are proud to partner in developing novel therapies for Multiple Sclerosis as part of a new Innovate UK accepted grant.

This new Venture plans to fight Multiple Sclerosis through ‘NanoMedicine’, which is supported by Cambridge Judge Business School.
The grant itself has been funded £1 million new funding to explore this dieases area. Of the £1 million funding receieved more than £828,000 will be through the government’s Innovate UK BioMedical Catalyst Competition awarded to LIFNanoRx – which has brought together a project team that includes Pharmidex; the University of London’s Blizard Institute – a world-renowned center for treatment of MS; and the Government’s Center for Process Innovation.
You can find more information on the following website:
http://www.epe.admin.cam.ac.uk/grant-lifnanorx


